Skip to content
2000
Volume 16, Issue 2
  • ISSN: 1875-6921
  • E-ISSN: 1875-6913

Abstract

Background: Cancer is a series of different disease (>200 different sub-types) with an identical feature of unlimited growth, invasive and multi-step/multi-level metastasis processes. Objective: Individualized cancer therapies/personalized cancer therapies will undergo a dramatic evolution to cope with this disease diversity and a complexity of tumor genes/biomarkers. Methods: The next generation of personalized cancer therapy must simultaneously contain information of pharmacology (drug sensitivity or drug combination), oncology (tumor etiopathological information), computational network (predictive of cancer risks and therapeutic efficacy), toxicology (adverse side-effects and human mortality), artificial intelligence and patient's desire (decision-aid), especially technology merge. Results: Future multi-functional approach is inevitable. After all, multi-functional personalized cancer therapy (collective and balanced regime/paradigms) might take formation in the future. Conclusion: A reliable, safe, effective and collective platform can be established through further scientific and technical approaches in the clinic.

Loading

Article metrics loading...

/content/journals/cppm/10.2174/1875692116666180821095434
2018-06-01
2025-09-01
Loading full text...

Full text loading...

/content/journals/cppm/10.2174/1875692116666180821095434
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test